Cargando…
P-21 Activated Kinases in Liver Disorders
SIMPLE SUMMARY: Liver disorders, particularly liver cancer and hepatitis, are considered major public health challenges. Nearly 90% of patients with liver cancer are diagnosed at late stages of the disease, which reduces the treatment options, having a significant negative impact on patient survival...
Autores principales: | Qiu, Xun, Xu, Hanzhi, Wang, Kai, Gao, Fengqiang, Xu, Xiao, He, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857091/ https://www.ncbi.nlm.nih.gov/pubmed/36672500 http://dx.doi.org/10.3390/cancers15020551 |
Ejemplares similares
-
ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1
por: Wang, Kai, et al.
Publicado: (2023) -
Targeting the Hepatic Microenvironment to Improve Ischemia/Reperfusion Injury: New Insights into the Immune and Metabolic Compartments
por: Gao, Fengqiang, et al.
Publicado: (2022) -
p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
por: Wang, Kai, et al.
Publicado: (2018) -
The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders
por: Zhang, Kaifan, et al.
Publicado: (2020) -
p21-activated kinase signaling in breast cancer
por: Gururaj, Anupama E, et al.
Publicado: (2005)